Bibliographic Details
| Title: |
Strengthening strategic management approaches to address antimicrobial resistance in global human health: a scoping review |
| Authors: |
Andrew J M Leather, Nick Sevdalis, Andy Leather, Raheelah Ahmad, Nina Jiayue Zhu, Esmita Charani, Sanjeev Singh, Alison Holmes, Ewan Ferlie, Gabriel Birgand, Enrique Castro-Sánchez, Puneet Dhar, Ewan Balfour Ferlie, Mark Ian Hampton, Alison H Holmes [PI], Mohamed Reda Lebcir, Marc Mendelson, Jules Ndoli Minega, Franco Sassi, Carolyn Clare Tarrant |
| Source: |
BMJ Global Health, Vol 4, Iss 5 (2019) |
| Publisher Information: |
BMJ Publishing Group, 2019. |
| Publication Year: |
2019 |
| Collection: |
LCC:Medicine (General)
LCC:Infectious and parasitic diseases |
| Subject Terms: |
Medicine (General), R5-920, Infectious and parasitic diseases, RC109-216 |
| More Details: |
Introduction The development and implementation of national strategic plans is a critical component towards successfully addressing antimicrobial resistance (AMR). This study aimed to review the scope and analytical depth of situation analyses conducted to address AMR in human health to inform the development and implementation of national strategic plans.Methods A systematic search of the literature was conducted to identify all studies since 2000, that have employed a situation analysis to address AMR. The included studies are analysed against frameworks for strategic analysis, primarily the PESTELI (Political, Economic, Sociological, Technological, Ecological, Legislative, Industry) framework, to understand the depth, scope and utility of current published approaches.Results 10 studies were included in the final review ranging from single country (6) to regional-level multicountry studies (4). 8 studies carried out documentary review, and 3 of these also included stakeholder interviews. 2 studies were based on expert opinion with no data collection. No study employed the PESTELI framework. Most studies (9) included analysis of the political domain and 1 study included 6 domains of the framework. Technological and industry analyses is a notable gap. Facilitators and inhibitors within the political and legislative domains were the most frequently reported. No facilitators were reported in the economic or industry domains but featured inhibiting factors including: lack of ring-fenced funding for surveillance, perverse financial incentives, cost-shifting to patients; joint-stock drug company ownership complicating regulations.Conclusion The PESTELI framework provides further opportunities to combat AMR using a systematic, strategic management approach, rather than a retrospective view. Future analysis of existing quantitative data with interviews of key strategic and operational stakeholders is needed to provide critical insights about where implementation efforts should be focussed, and also how to build contingency at the strategic level for agile responses to macro-level environmental influences. |
| Document Type: |
article |
| File Description: |
electronic resource |
| Language: |
English |
| ISSN: |
2059-7908 |
| Relation: |
https://gh.bmj.com/content/4/5/e001730.full; https://doaj.org/toc/2059-7908 |
| DOI: |
10.1136/bmjgh-2019-001730 |
| Access URL: |
https://doaj.org/article/41384412e0814c238ee879c98d631cf2 |
| Accession Number: |
edsdoj.41384412e0814c238ee879c98d631cf2 |
| Database: |
Directory of Open Access Journals |
